Doximity, LivaNova downgraded as Goldman Sachs reviews MedTech and Health IT coverage
Source: SeekingAlpha
2025-10-01 13:57:07 ET
More on Doximity, LivaNova PLC, etc.
- Doximity: Valuation Is Too Expensive For My Liking
- LivaNova PLC (LIVN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Beta Bionics, Inc. (BBNX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Doximity rises on Q1 beat; buys Canadian AI-based clinical reference firm
- Doximity outlines 11% full-year revenue growth target as AI suite and Pathway acquisition accelerate platform expansion
Read the full article on Seeking Alpha
For further details see:
Doximity, LivaNova downgraded as Goldman Sachs reviews MedTech and Health IT coverage
Doximity Inc. Class A
NASDAQ: DOCS
DOCS Trading
-0.21% G/L:
$24.34 Last:
691,911 Volume:
$24.61 Open:
DOCS Latest News
February 23, 2026 01:35:00 am
Got $50,000? This Unbelievable SaaS Compounder Is Hiding in Plain Sight.
DOCS Stock Data
$5,029,624,926
180,645,361
N/A
184
N/A
Healthcare Providers & Services
Healthcare
US
San Francisco
